Alberto M Borobia - JoVE Visualize

Showing results (91-100 of 105) with videos related to

Pageof 11

Sort By:

Pharmaceuticals (Basel, Switzerland)|January 21, 2022

A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching AnalysisJaime Monserrat Villatoro, Gina Mejía-Abril, Lucía Díaz García, et al.

Lancet (London, England)|June 28, 2021

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trialAlberto M Borobia, Antonio J Carcas, Mayte Pérez-Olmeda, et al.

Frontiers in Immunology|May 21, 2026

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamicsRocío Maseda, María Carmen Arriba, Lucía Martínez-Santamaría, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2022

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical TrialRocío Montejano, Fernando de la Calle-Prieto, María Velasco, et al.

Journal of Clinical Medicine|February 25, 2022

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical TrialIrene García-García, Enrique Seco-Meseguer, Pilar Ruiz-Seco, et al.

Iscience|September 17, 2024

Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variantsJavier García-Pérez, Alberto M Borobia, Mayte Pérez-Olmeda, et al.

Eclinicalmedicine|July 7, 2022

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS studyJavier García-Pérez, María González-Pérez, María Castillo de la Osa, et al.

Journal of Clinical Medicine|June 10, 2020

A Cohort of Patients with COVID-19 in a Major Teaching Hospital in EuropeAlberto M Borobia, Antonio J Carcas, Francisco Arnalich, et al.

Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 2, 2020

A case-control study to assess the role of polyomavirus in transplant complications: Where do we stand?Julia Garcia Urbán, Katia Gurrado, Paola C Brea Rivas, et al.

Cytotherapy|October 28, 2023

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín-Quirós, et al.

Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:

Pageof 11

Pharmaceuticals (Basel, Switzerland)|January 21, 2022

A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching AnalysisJaime Monserrat Villatoro, Gina Mejía-Abril, Lucía Díaz García, et al.

Lancet (London, England)|June 28, 2021

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trialAlberto M Borobia, Antonio J Carcas, Mayte Pérez-Olmeda, et al.

Frontiers in Immunology|May 21, 2026

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamicsRocío Maseda, María Carmen Arriba, Lucía Martínez-Santamaría, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2022

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical TrialRocío Montejano, Fernando de la Calle-Prieto, María Velasco, et al.

Journal of Clinical Medicine|February 25, 2022

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical TrialIrene García-García, Enrique Seco-Meseguer, Pilar Ruiz-Seco, et al.

Iscience|September 17, 2024

Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variantsJavier García-Pérez, Alberto M Borobia, Mayte Pérez-Olmeda, et al.

Eclinicalmedicine|July 7, 2022

Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS studyJavier García-Pérez, María González-Pérez, María Castillo de la Osa, et al.

Journal of Clinical Medicine|June 10, 2020

A Cohort of Patients with COVID-19 in a Major Teaching Hospital in EuropeAlberto M Borobia, Antonio J Carcas, Francisco Arnalich, et al.

Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 2, 2020

A case-control study to assess the role of polyomavirus in transplant complications: Where do we stand?Julia Garcia Urbán, Katia Gurrado, Paola C Brea Rivas, et al.

Cytotherapy|October 28, 2023

Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín-Quirós, et al.

Pageof 11